Lysogene panellist and presenter at conference, “Partnering well together – Creating a Global Ecosystem for Advanced Therapies”.
Lysogene presents at the Europabio Patients Bio-Forum meeting entitled, “How to make the most of European Reference Networks (ERNs)?”
Lysogene presents at Gene Therapy for Rare Diseases Europe
Lysogene presents a poster "Widespread brain distribution of SGSH enzyme in canine brain following white matter injection of LYS-SAF302, an AAVrh.10-SGSH vector" at 25th Anniversary Congress of the ESGCT
Lysogene presents at the ARM Cell and Gene Meeting on the Mesa Partnering Forum
La Jolla, US
Karen Aiach presents at the “5èmes rencontres des maladies rares”.
Lysogene Chief Patient Access Officer moderates breakout session at 25th workshop of the Eurordis Round Table of Companies (ERTC)
Casa Convalescencia, Barcelona.
Lysogene presents "Gene therapy potency assay development" at The Bioprocessing Summit 2017
Lysogene hosts interactive round table at the World Orphan Drug Conference Washington
Samantha Parker from Lysogene will be discussing the status of clinical trial readiness in GM1 gangliosidosis at the NTSAD Annual Family Conference Research Session